Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 84
Selected: 0
NCT IDTitle
NCT03662568A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects
NCT04591301The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects
NCT04546984Multiple Dose Safety, Tolerability, PK,PD and Food Effect Study of HEC96719 in Healthy Adult Subjects
NCT04551261GLS4/RTV and TAF Drug-drug Interaction
NCT03888092Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification
NCT07376200Single-ascending Dose Study of HEC-151 Injection
NCT03462173The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects
NCT05060822Phase ll Study of HEC585 in Patients With IPF
NCT05057949A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants
NCT05294536A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
NCT03458481Phase 2 Study of Yimitasvir Phosphate Capsules
NCT04415853Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
NCT07588646Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects
NCT04422496The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects
NCT05459285A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects
NCT05133882A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
NCT03811678The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects
NCT07771140A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B
NCT05586074HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
NCT05127772A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing
NCT05451602HEC169096 in Participants With Advanced Solid Tumors
NCT03876925A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC
NCT05397379A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis
NCT05139719A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients
NCT07102251A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects
NCT04984512The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder
NCT04194242The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects
NCT05395416Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C
NCT05492630Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects
NCT04202952The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects
NCT04623814the Safety, Tolerability, and Pharmacokinetics Study of HEC113995
NCT05998304ADME Study of [14C] Yiqibuvir in Healthy Male Subjects
NCT03943251The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects
NCT03125876A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)
NCT05504876Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114
NCT05048368Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function
NCT03673696The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects
NCT04596007The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects
NCT04667429the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets
NCT05802862A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China
NCT03886688HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers
NCT05391360Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study
NCT03655873The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects
NCT05468346Study on the Body Mass Balance and Biotransformation of [14C]-HEC585
NCT05059743ADME Study of [14C]- Larotinib in Healthy Male Subjects
NCT07082842Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF
NCT05109078ADME Study of [14C]- Rongliflozin in Healthy Male Subjects
NCT03758287Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative
NCT07341672A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
NCT07099118A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects